The case comes from a phase 1 study of its ICAM ... and anaplastic thyroid cancer (ATC), which will be reported at the ASCO congress next week. CAR-T therapies have transformed the treatment ...
At ASCO, the numbers have been revealed, and the picture isn't much clearer. The trial evaluated Trodelvy (sacituzumab govitecan) in patients with HR-positive, HER2-negative metastatic breast ...
7d
Laramie Energy deployed ASCO zero-emissions electric dump valves to comply with state regulations, reduce maintenance and ...
ASCO Annual Meeting: Submissions open late-January and close early-March (late submissions are accepted on a case-by-case basis through mid-April; however, publication in time for the Annual Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results